---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-057240"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2024-06-28T23:59:59+00:00"
generated_at: "2026-06-01T00:42:40.030277+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics closes $8.75M public offering to repay debt and fund FDA work

## Summary
- Gross proceeds $8.75M from sale of 5,368,098 units at $1.63/unit.
- Units consist of 1 share (or pre-funded warrant), 2 Class C warrants, 1 Class D warrant.
- Net proceeds to repay $2.3M debt and fund FDA approval (incl. clinical studies), R&D, working capital.
- Class C warrants ($1.96 strike, 5-year term) require stockholder approval to become exercisable.
- Underwriting discount 8.5%; Aegis Capital Corp. acted as sole underwriter.

## SEC filing metadata
- accession: 0001213900-24-057240
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2024-06-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390024057240/0001213900-24-057240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390024057240/ea0208666-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-057240
- JSON: https://secwatch.observer/filing/0001213900-24-057240.json
- Plain text: https://secwatch.observer/filing/0001213900-24-057240.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.